Sutro Biopharma Inc
F:S090
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sutro Biopharma Inc
F:S090
|
US |
|
Uflex Ltd
BSE:500148
|
IN |
|
H
|
HLB Pep Co Ltd
KOSDAQ:196300
|
KR |
|
G
|
Geiger Energy Corp
NEO:BEEP
|
CA |
|
Santec Holdings Corp
TSE:6777
|
JP |
|
C
|
Cahayaputra Asa Keramik Tbk PT
IDX:CAKK
|
ID |
|
T
|
Toppan Inc
DUS:TPX
|
JP |
|
L
|
Leadcorp Inc
KOSDAQ:012700
|
KR |
|
P
|
Partners Group Holding AG
DUS:P2H
|
CH |
|
Rokeby Resources Ltd
ASX:RKB
|
AU |
|
H
|
Hanchang Ind Co Ltd
KOSDAQ:079170
|
KR |
|
Nippon Shindo Co Ltd
TSE:5753
|
JP |
|
C
|
CSBC Corp Taiwan
TWSE:2208
|
TW |
|
V
|
Vestas Wind Systems A/S
F:VWSB
|
DK |
|
PDF Solutions Inc
NASDAQ:PDFS
|
US |
|
W
|
WEYCO Group Inc
F:WY1
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
A
|
Autohome Inc
HKEX:2518
|
CN |
|
C
|
Cytogen Inc
KOSDAQ:217330
|
KR |
Bankruptcy Probability
Sutro Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sutro Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
164.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sutro Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sutro Biopharma Inc has total debt of 239.1m USD. This includes both short-term (0 USD) and long-term (239.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
